Interleukin-2 emerges as both engine and saboteur in tumor-infiltrating lymphocyte therapy
A new review details how interleukin-2 both powers and undermines tumor-infiltrating lymphocyte therapy, and how engineered alternatives may finally break ...
A new review details how interleukin-2 both powers and undermines tumor-infiltrating lymphocyte therapy, and how engineered alternatives may finally break ...
Scientists have transformed a sugar molecule produced by gut bacteria into a self-assembling nanovaccine that dramatically boosts antitumor immunity and ...
A meta-analysis of 38 clinical trials finds oncolytic herpes simplex virus therapy delivers modest anti-tumor activity across solid tumors, with ...
Researchers at University Hospital Tübingen have engineered NG2-targeting bispecific antibodies that redirect T cells to kill melanoma cells, with a ...
A Mayo Clinic review of 326 early-stage melanoma patients treated with Mohs micrographic surgery found that the width of the ...
Researchers have engineered T cell receptors fused to the co-stimulatory molecule ICOS, producing T cells that persist longer, resist exhaustion ...
Australian researchers have shown that blocking the BRN2 transcription factor reverses anoikis resistance in melanoma cells and sensitizes them to ...
A comprehensive analysis of Nordic cancer registry data from 2003 to 2022 shows incidence rates rising for 12 of 18 ...
New research shows that activating bystander T cells inside tumors triggers antigen-independent tumor killing through cytokines, nitric oxide and innate ...
A UK-wide discrete choice experiment reveals that the public supports AI-assisted skin cancer detection in general practice when clinicians remain ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine